|
2012
|
EMPA
|
Orexin type 2 (OX2) receptor antagonist |
€135.00
|
|
2146
|
Fedovapagon
|
Selective vasopressin V2 receptor agonist |
€140.00
|
|
3805
|
MK-3697
|
Potent and selective Orexin receptor antagonist |
Inquire
|
|
2321
|
ML 154
|
Competitive, selective, and brain penetrant NPS receptor antagonist |
€120.00
|
|
2095
|
SB 334867
|
First selective orexin 1 (OX1) antagonist |
€90.00
|
|
2192
|
SB 674042
|
Nonpeptide OX1 selective antagonist with >100 fold selectivity over the OX2 receptor. |
€99.00
|
|
1245
|
SR 27897
|
CCK1 antagonist |
€120.00
|
|
1256
|
SR 49059
|
Vasopressin (V1A) antagonist |
€130.00
|
|
1114
|
SSR 149415
|
Vasopressin (V1B) antagonist |
€130.00
|
|
1270
|
T 98475
|
GnRH or LHRH antagonist |
Inquire
|
|
2744
|
TCS1102
|
Dual orexin (OX1/2) receptor antagonist |
€90.00
|
|
1591
|
Tolvaptan
|
Vasopressin (V2) antagonist |
€110.00
|
|
1867
|
Vasopressin antagonist 1867
|
Orally available and selective V1b receptor antagonist |
€150.00
|